| Zinc Undecylenate as per BP/EP/USP |
| PARAMETERS | SPECIFICATIONS |
| Synonyms | Undecylenic Acid Zinc Salt Mycoseptin Tineafax |
| CAS No. | 557-08-4 |
| Formula | [H2C=CH(CH2)8CO2]2 Zn |
| Mol. Wt. | 431.9 |
| Assay as C22H38O4Zn | 98% w/w to 102% w/w |
| Purity | 99% min by GLC. |
| Appearance & Color | A White fine powder. Melts at 120o C. |
| Loss on Drying at 105C | 1.5%max. |
| Sulphate | 500 ppm max. |
| Alkalies & Alkaline Earths | 2.0% Max. |
| Alkalinity | Passes B.P.Test |
| Identification Tests | Positive. |
| Melting Point | 116-121o C |
| Solubility Test | Practically insoluble in water, ethanol(96%) and in ether. |
| Packaging | The material is packed 60 kg net HMHDPE drums open mouth ring with poly bags on the inside |
Acme Synthetic Chemicals is the Manufacturer, Supplier & also the Exporter of Zinc Undecylenate as per BP/EP/USP.
Zinc Undecylenate - Pharma Ingredient is also known as Undecylenic Acid Zinc Salt Mycoseptin Tineafax which is classified under CAS No.557-08-4.
Acme Synthetic Chemicals is one of the reputed organizations engaged in providing superior quality Zinc Undecylenate - Pharma Ingredient to our esteemed clients.
Zinc Undecylenate - Pharma Ingredient, Undecylenic Acid Zinc Salt Mycoseptin Tineafax (CAS No.557-08-4) is used as an active ingredient in powders and ointments for athlete's foot.
Zinc Undecylenate - Pharma Ingredient, Undecylenic Acid Zinc Salt Mycoseptin Tineafax (CAS No.557-08-4) powder meets all requirements of BP, USP and EP.
Zinc Undecylenate - Pharma Ingredient, Undecylenic Acid Zinc Salt Mycoseptin Tineafax (CAS No.557-08-4) is used for its anti-fungal properties.
Zinc Undecylenate - Pharma Ingredient, Undecylenic Acid Zinc Salt Mycoseptin Tineafax (CAS No.557-08-4) is a very economical anti-fungal agent and is used as an active ingredient in many topical over the counter anti-fungal preparations, both powders and ointments.
The Zinc Undecylenate - Pharma Ingredient, Undecylenic Acid Zinc Salt Mycoseptin Tineafax (CAS No.557-08-4) provides an astringent action, reducing rawness and irritation Fungicide.
Zinc Undecylenate - Pharma Ingredient, Undecylenic Acid Zinc Salt Mycoseptin Tineafax (CAS No.557-08-4) act as co-emulsifier in personal care products & as Fungicide, antibacterial agent in medicine.
Zinc Undecylenate - Pharma Ingredient, Undecylenic Acid Zinc Salt Mycoseptin Tineafax (CAS No.557-08-4) is reported to be specially effective for athletes' foot and similar infections.
Our Zinc Undecylenate - Pharma Ingredient, Undecylenic Acid Zinc Salt Mycoseptin Tineafax (CAS No.557-08-4) is manufactured by a group company which has a FDA License and is locally certified as CGMP.
We can supply Zinc Undecylenate - Pharma Ingredient, Undecylenic Acid Zinc Salt Mycoseptin Tineafax (CAS No.557-08-4) as per USP with relevant COA.
Our current capacity for Zinc Undecylenate - Pharma Ingredient (Undecylenic acid Zinc salt, CAS No.557-08-4) is 350 tons per annum.
Zinc Undecylenate - Pharma Ingredient is formulated using supreme class ingredients and modern techniques by our team of skilled professionals as per the set industry norms at our state-of-the-art processing unit.
Zinc Undecylenate - Pharma Ingredient is widely demanded in the international market due to its high effectiveness, eco-friendliness & purity, and is offered in different packaging options to meet the varied needs of our clients. Moreover, we are offering the entire range at an affordable cost to our clients.
Zinc Undecylenate upholds consistent quality with a shelf life of 5 years when stored in cool, dry, tightly closed containers. Its stability further guarantees its efficacy as an ingredient in long-lasting pharmaceutical and dermatological applications, minimizing the risk of degradation even under extended storage conditions.
Manufactured to comply with BP/USP and pharmacopeial microbial limits, this pharmaceutical-grade ingredient meets rigorous industry requirements. Users gain assurance of its safety, efficacy, and purity, essential for dermatological preparations and topical antifungal formulations.
Zinc Undecylenate is selected for its excellent antifungal properties, making it ideal for creams, ointments, and powders designed to treat various skin conditions. Its insolubility in water and compatibility with mineral acids and alkalies allow flexible integration into multiple pharmaceutical formats.
FAQs of Zinc Undecylenate - Pharma Ingredient:
Q: How should Zinc Undecylenate be stored to maintain its stability?
A: Zinc Undecylenate should be stored in a cool, dry place within tightly closed containers to preserve its quality and ensure stability for up to 5 years.
Q: What is the primary application of Zinc Undecylenate in pharmaceuticals?
A: It is predominantly used as an antifungal agent in topical preparations, including creams and ointments for dermatological treatments.
Q: When is Zinc Undecylenate recommended for use in pharmaceutical production?
A: Zinc Undecylenate is recommended when a high-purity, stable antifungal ingredient is required for pharmaceutical or dermatological product formulations.
Q: Where does Zinc Undecylenate find its major market as a pharma ingredient?
A: Its major market includes pharmaceutical manufacturers, suppliers, and traders primarily in India, where it is exported for topical and dermatological uses.
Q: What benefits does Zinc Undecylenate offer in topical preparations?
A: The ingredient delivers effective antifungal action, is non-poisonous, odourless, tasteless, and maintains high purity and stability, ensuring safe and consistent results in patient care.
Q: How is the quality of Zinc Undecylenate ensured during production?
A: Each batch complies with BP/USP standards and passes pharmacopeial microbial limit tests, guaranteeing pharmaceutical-grade quality and safety for end users.
Q: What process should be followed to utilize Zinc Undecylenate in formulations?
A: Manufacturers should measure precise quantities according to pharmaceutical recipes, ensuring the powder passes 200 mesh for uniform distribution in creams or ointments, and account for its insolubility in water when choosing compatible formulation bases.